title: Molecular Imaging in the Evaluation of 6 Doses of Ra-223 in High-Grade Prostate Cancer: Case Report.
authors.affiliation: Nuclear Medicine and Molecular Imaging Department, INCan, Mexico City, Mexico. Electronic address: dr.sevastian@outlook.com.
authors.forename: Sevastián S
authors.initials: SS
authors.lastname: Medina-Ornelas
authors.affiliation: Nuclear Medicine and Molecular Imaging Department, INCan, Mexico City, Mexico.
authors.forename: Francisco O
authors.initials: FO
authors.lastname: García-Pérez
mesh_terms: D000954:Antigens, Surface / Q000378:metabolism; D017326:Clinical Trials, Phase III as Topic; D043425:Glutamate Carboxypeptidase II / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D057054:Molecular Imaging / Q000379:methods*; D000072078:Positron Emission Tomography Computed Tomography; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D019275:Radiopharmaceuticals / Q000008:administration & dosage*; D011883:Radium / Q000008:administration & dosage*
chemical_list: D000954:Antigens, Surface; D019275:Radiopharmaceuticals; C000615150:Radium-223; C473848:FOLH1 protein, human; D043425:Glutamate Carboxypeptidase II; D011883:Radium
keywords: High-grade prostate cancer; NaF; PET/CT; PSMA; Radium-223